Home > Healthcare > Medical Devices > Surgical Devices > Pediatric Perfusion Systems Market

Pediatric Perfusion Systems Market Size

  • Report ID: GMI7499
  • Published Date: Nov 2023
  • Report Format: PDF

Pediatric Perfusion Systems Market Size

Pediatric Perfusion Systems Market size was valued at USD 318.9 million in 2022 and is projected to register a CAGR of over 6.8% between 2023 and 2032. This robust market growth is attributed to factors such as growing demand for minimally invasive procedures in pediatric cardiac surgery, increasing favorable government initiatives and reimbursement policies, and growing awareness about the importance of pediatric cardiac care, among others are driving the market development. Additionally, the rising prevalence of congenital heart defects in paediatric populations is a significant factor in the market progress.

 

Moreover, perfusion devices to facilitate corrective operations are in high demand as awareness and early identification of CHDs are on rise. For instance, according to American Heart Association, Inc.’s fact sheet 2022, congenital heart defects are expected to affect around 40,000 infants in the U.S. each year. In the first year of life, approximately 25%, or 2.4 per 1,000 live newborns, require invasive therapy. Therefore, the aforementioned factors contribute to the growth of the market by fostering advancements in technology and enhancing the overall quality of care for paediatric patients undergoing cardiac procedures.
 

Pediatric perfusion systems refer to medical devices and systems designed specifically for managing the circulation and oxygenation of blood in pediatric patients during cardiac surgery or other medical procedures requiring temporary circulatory support.
 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The pediatric perfusion systems industry was valued at USD 318.9 million in 2022 and is estimated to reach over USD 627 million by 2032, attributed to the growing demand for minimally invasive procedures in pediatric cardiac surgery, favorable government initiatives and reimbursement policies.

The pediatric oxygenators segment garnered around USD 99.1 million revenue in 2022. Due to congenital heart defects, neonates and newborns often require cardiac surgeries or procedures, pushing the demand for the specialised oxygenation to meet the physiological requirements of the youngest patients.

North America pediatric perfusion system market accounted for USD 131.6 million in 2022 and is predicted to witness substantial growth as there is a growing focus on pediatric cardiac care in the region, leading to increased investments in specialized services and technologies.

Medtronic, LivaNova PLC, Terumo Cardiovascular Systems Corporation, BL Lifesciences, Cardinal Health, EUROSETS, Getinge AB, Nonin, Edwards Lifesciences Corporation, and Stryker Corporation.

Pediatric Perfusion Systems Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 10
  • Tables & Figures: 212
  • Countries covered: 22
  • Pages: 120
 Download Free Sample